Keros Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $54M | 1.2M | 45.72 |
| 2024-03-31 | $81M | 1.2M | 66.20 |
| 2023-12-31 | $41M | 1.0M | 39.76 |
| 2023-09-30 | $40M | 1.3M | 31.88 |
| 2023-06-30 | $51M | 1.3M | 40.18 |
| 2023-03-31 | $49M | 1.2M | 42.70 |
| 2022-12-31 | $30M | 621k | 48.02 |
| 2022-03-31 | $245k | 4.5k | 54.38 |
| 2021-12-31 | $384k | 6.6k | 58.47 |